Pentagon, Berg unite to ID prostate cancer biomarkers

The Department of Defense has teamed up with Berg to discover biomarkers for prostate cancer with the goal of identifying more effective treatments for the disease. Berg will analyze prostate cancer data using its Interrogative Biology technology. The collaboration is part of a cooperative research and development agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine and the Center for Prostate Disease Research of the Uniformed Services University of the Health Sciences.

View Full Article in:

Genetic Engineering & Biotechnology News · GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Director of Professional Services
Engaging Schools, Inc.
Cambridge, MA
Principal at Timberland Charter Academy
Timberland Charter Academy
Muskegon, MI
VP - Partnership Operations
Discovery Communications
Silver Spring, MD
Principal at Hamtramck Academy
National Heritage Academies
Hamtramck, MI
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL